ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,849Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 58

$574K Total Retail Price of All Prescriptions

Rank: 7 out of 58

328 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 328 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 328 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 6,707 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 739 513 1 1
HYDROCODONE-ACETAMINOPHEN 514 218 S3 2 11
LISINOPRIL 475 336 3 3
METOPROLOL TARTRATE 421 271 4 6
OMEPRAZOLE 329 226 5 4
AMLODIPINE BESYLATE 298 231 6 2
METFORMIN HCL 227 149 7 8
OXYCODONE HCL 208 23 S2 8 57
FUROSEMIDE 199 141 9 7
HYDROCHLOROTHIAZIDE 195 120 10 10
POTASSIUM CHLORIDE 192 117 11 21
GABAPENTIN 186 94 12 14
LEVOTHYROXINE SODIUM 159 121 13 5
GLIPIZIDE ER 135 97 14 65
OXYCODONE-ACETAMINOPHEN 135 70 S2 14 64
NIFEDIPINE ER 115 85 16 53
METOPROLOL SUCCINATE 107 78 17 22
AMOXICILLIN 106 57 18 99
TRAMADOL HCL 103 57 19 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 76 19 25
INSULIN SYRINGE 101 56 21 82
PROAIR HFA 98 66 22 72
CYCLOBENZAPRINE HCL 96 24 R 23 69
LABETALOL HCL 94 58 24 149
CARISOPRODOL 93 0 R 25 91
CRESTOR 92 45 26 23
ADVAIR DISKUS 91 77 27 59
CARVEDILOL 88 59 28 26
ZOLPIDEM TARTRATE 86 40 29 16
ATORVASTATIN CALCIUM 85 59 30 17
CLOPIDOGREL 85 63 30 24
ENALAPRIL MALEATE 85 52 30 35
NIASPAN 82 62 33 108
DONEPEZIL HCL 81 81 34 29
CLONIDINE HCL 81 55 34 45
MIRTAZAPINE 78 64 36 58
IBUPROFEN 77 42 37 46
PLAVIX 74 52 38 39
NOVOLIN 70-30 74 49 38 124
DIOVAN 73 51 40 43
OXYCODONE HCL-ACETAMINOPHEN 71 18 S2 41 87
JANUVIA 66 35 42 77
ALLOPURINOL 58 40 43 38
ALENDRONATE SODIUM 56 56 44 18
NOVOLIN R 53 38 45 118
LANTUS 53 26 45 51
SANTYL 52 0 47 223
TAMSULOSIN HCL 51 34 48 37
ONGLYZA 50 39 49 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.